Pacing Therapies for Atrial Fibrillation

  • Michael A. Platonov
  • Anne M. Van Hare

Atrial fibrillation (AF) occurs frequently in the pacemaker population particularly in those with sinus node dysfunction as the primary indication for cardiac pacing (1–3). Clinical trials have demonstrated that atrial pacing prevents paroxysmal and persistent AF in the general pacemaker population and the greatest benefit is observed in patients with sinus node disease (1–4). Many dual chamber pacemakers now have specific algorithms designed to suppress AF (4,5). In addition, there has been considerable interest in selective atrial pacing sites and prevention of AF (4,5).


Atrial Fibrillation Ventricular Pace Atrial Pace Sinus Node Dysfunction Atrial Tachyarrhythmia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Andersen HR, Nielsen JC, Thomsen FEB, et al. Long-term follow-up of patients from a randomized trial of atrial versus ventricular pacing for sick-sinus syndrome. Lancet 1997;350:1210–16.CrossRefPubMedGoogle Scholar
  2. 2.
    Connolly SJ, Kerr CR, Gent M, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. N Eng J Med 2000;342:1385–91.CrossRefGoogle Scholar
  3. 3.
    Lamas GA, Lee KL, Sweeney MO, et al. Ventricular pacing or dual-chamber pacing for sinus-node dysfunction. N Eng J Med 2002;346:1854–62.CrossRefGoogle Scholar
  4. 4.
    Gillis AM. Clinical trials of pacing for maintenance of sinus rhythm. J Interv Card Electrophysiol 2004;10(Suppl 1):55–62.CrossRefPubMedGoogle Scholar
  5. 5.
    Savelieva I, Camm AJ. The results of pacing trials for the prevention and termination of atrial tachyarrhythmias: is there any evidence of therapeutic breakthrough? J Interv Card Electrophysiol 2003;8:103–15.CrossRefPubMedGoogle Scholar
  6. 6.
    Lamas GA, Orav EJ, Stambler BS, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Eng J Med 1998;338:1097–104.CrossRefGoogle Scholar
  7. 7.
    Toff WD, Camm AJ, Skehan JD. Single-chamber versus dual-chamber pacing for high-grade atrioventricular block. N Eng J Med 2005;353:145–55.CrossRefGoogle Scholar
  8. 8.
    Nielsen JC, Lene Kristensen, Henning R. Andersen, et al. A randomized comparison of atrial and dual-chamber pacing in177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol 2003;42:614–23.CrossRefGoogle Scholar
  9. 9.
    Stambler BS, Ellenbogen KA, Orav EJ, et al. Predictors and clinical impact of atrial fibrillation after pacemaker implantation in elderly patients treated with dual chamber versus ventricular pacing. PACE 2003;26:2000–7.PubMedGoogle Scholar
  10. 10.
    Kerr CR, Connolly SJ, Abdollah MB, et al. Canadian trial of physiological pacing: effects of physiological pacing during long-term follow-up. Circulation 2004;109:357–62.CrossRefPubMedGoogle Scholar
  11. 11.
    Sweeney MO, Hellkamp AS, Ellenbogen KA, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003;107:2932–7.CrossRefPubMedGoogle Scholar
  12. 12.
    Healey JS, Toff WD, Lamas GA, et al. Cardiovascular outcomes with atrial-based pacing compared with ventricular pacing. Circulation 2006;114:11–17.CrossRefPubMedGoogle Scholar
  13. 13.
    Fleischmann KE, Orav EJ, Lamas GA, et al. Pacemaker implantation and quality of life in the Mode Selection Trial (MOST). Heart Rhythm 2006;3:653–9.CrossRefPubMedGoogle Scholar
  14. 14.
    O’Brien BJ, Blackhouse G, Goeree R, et al. Cost-effectiveness of physiologic pacing: results of the Canadian health economic assessment of physiologic pacing. Heart Rhythm 2005;2:270–5.CrossRefPubMedGoogle Scholar
  15. 15.
    Ellenbogen KA, Hellkamp AS, Wilkoff BL, et al. Complications arising after implantation of DDD pacemakers: the MOST experience. Am J Cardiol 2003;92:740–9.CrossRefPubMedGoogle Scholar
  16. 16.
    Gillis AM. Redefining physiologic pacing: lessons learned from recent clinical trials. Heart Rhythm 2006;3:1367–72.CrossRefPubMedGoogle Scholar
  17. 17.
    Link MS, Hellkamp AS, Estes NAM, et al. High incidence of pacemaker syndrome in patients with sinus node dysfunction treated with ventricular-based pacing in the Mode Selection Trial. J Am Coll Cardiol 2004;43:2066–71.CrossRefPubMedGoogle Scholar
  18. 18.
    Gillis AM, Purerfellner H, Israel CW, et al. Reducing unnecessary right ventricular pacing with the managed ventricular pacing mode in patients with sinus node disease and AV block. Pacing Clin Electrophysiol 2006;29:697–705.CrossRefPubMedGoogle Scholar
  19. 19.
    Carlson MD, Ip J, Messenger J, Beau S, Kalbfleisch S, et al. A new pacemaker algorithm for the treatment of atrial fibrillation: results of the Atrial Dynamic Overdrive Pacing Trial (ADOPT). J Am Coll Cardiol. 2003;42:627–33.CrossRefPubMedGoogle Scholar
  20. 20.
    Padeletti L, Purerfellner H, Adler SW, et al. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 2003;14:1189–95.CrossRefPubMedGoogle Scholar
  21. 21.
    Lewalter T, Yang A, Pfeiffer D, et al. Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP registry. Pacing Clin Electrophysiol 2006;29:124–34.CrossRefPubMedGoogle Scholar
  22. 22.
    Purerfellner H, Ruiter JH, Widdershoven JW, et al. Reduction of atrial tachyarrhythmia episodes during the overdrive pacing period using the post-mode switch overdrive pacing (PMOP) algorithm. Heart Rhythm 2006;3:1164–71.CrossRefPubMedGoogle Scholar
  23. 23.
    Gillis AM, Unterberg-Buchwald C, Schmidinger H, et al. Safety and efficacy of advanced atrial pacing therapies for atrial tachyarrhythmias in patients with a new implantable dual chamber cardioverter-defibrillator. J Am Coll Cardiol 2002;40:1653–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Israel CW, Ehrlich JR, Gronefeld G, et al. Prevalence, characteristics and clinical implications of regular atrial tachyarrhythmias in patients with atrial fibrillation: insights from a study using a new implantable device. J Am Coll Cardiol 2001;38:355–63.CrossRefPubMedGoogle Scholar
  25. 25.
    Lee MA, Weachter R, Pollak S, et al. The effect of atrial pacing therapies on atrial tachyarrhythmia burden and frequency: results of a randomized trial in patients with bradycardia and atrial tachyarrhythmias. J Am Coll Cardiol 2003;41:1926–32.CrossRefPubMedGoogle Scholar
  26. 26.
    Mabo P and the Leaf Study Group. The LEAF (Loe Energy in Atrial Fibrillation) study results: Evaluation of device based therapies for atrial tachyarrhythmia prevention and termination. Heart Rhythm 2005;2:S17.CrossRefGoogle Scholar
  27. 27.
    Gillis AM, Koehler J, Morck M, et al. High atrial antitachycardia pacing therapy efficacy is associated with a reduction in atrial tachyarrhythmia burden in a subset of patients with sinus node dysfunction and paroxysmal atrial fibrillation. Heart Rhythm 2005;2:791–6.CrossRefPubMedGoogle Scholar
  28. 28.
    Yu W, Tsai C, Hsieh M, et al. Prevention of the initiation of atrial fibrillation: mechanism and efficacy of differential atrial pacing modes. Pacing Clin Electrophysiol 2000;23:373–9.CrossRefPubMedGoogle Scholar
  29. 29.
    Ants M, Otomo K, Arruda M, et al. Electrical conduction between the right atrium and the left atrium via the musculature of the coronary sinus. Circulation 1998; 98:1790–5.Google Scholar
  30. 30.
    Bennett DH. Comparison of the acute effects of pacing the atrial septum, right atrial appendage, coronary sinus os, and the latter two sites simultaneously on the duration of atrial activation. Heart 2000; 84:193–6.CrossRefPubMedGoogle Scholar
  31. 31.
    Padeletti L, Pieragnoli P, Ciapetti C, et al. Randomized crossover comparison of right atrial appendage pacing versus interatrial septum pacing for prevention of paroxysmal atrial fibrillation in patients with sinus bradycardia. Am Heart J 2001;142:1045–55.CrossRefGoogle Scholar
  32. 32.
    Padeletti L, Purerfellner H, Adler S, et al. Combined efficacy of atrial septal lead placement and atrial pacing algorithms for prevention of paroxysmal atrial tachyarrhythmia. J Cardiovasc Electrophysiol 2003;14:1189–95.CrossRefPubMedGoogle Scholar
  33. 33.
    Khaja A, Flaker G. Bachmann’s Bundle: does it play a role in atrial fibrillation? Pacing Clin Electrophysiol 2005;28:855–63.CrossRefPubMedGoogle Scholar
  34. 34.
    Bailin SJ. Is Bachmann’s Bundle the only right site for single-site pacing to prevent atrial fibrillation? Results of a multicenter randomized trial. Card Electrophysiol Rev 2003;7:325–8.CrossRefPubMedGoogle Scholar
  35. 35.
    Duytschaever M, Firsovaite V, Colpaert R, et al. Limited benefit of septal pre-excitation in pace prevention of atrial fibrillation. J Cardiovasc Electrophysiol 2005;16:269–77.CrossRefPubMedGoogle Scholar
  36. 36.
    Hermida J, Carpentier C, Kubala M, et al. Atrial septal versus atrial appendage pacing: feasibility and effects on atrial conduction, interatrial synchronization and atrioventricular sequence. Pacing Clin Electrophysiol 2003;26[Pt. 1]:26–35.CrossRefPubMedGoogle Scholar
  37. 37.
    Hermida JS, Kulbala M, Lescure FX, et al. Atrial septal pacing to prevent atrial fibrillation in patients with sinus node dysfunction: results of a randomized controlled study. Am Heart J 2004;148:312–7.CrossRefPubMedGoogle Scholar
  38. 38.
    Saksena S, Prakash A, Hill M, et al. Prevention of recurrent atrial fibrillation with chronic dual-site right atrial pacing. J Am Coll Cardiol 1996;24:687–94.CrossRefGoogle Scholar
  39. 39.
    Levy T, Walker S, Rochelle J, et al. Evaluation of biatrial pacing, right atrial pacing, and no pacing in patients with drug refractory atrial fibrillation. Am J Cardiol 1999;82:426–9.CrossRefGoogle Scholar
  40. 40.
    Mirza I, James S, Holt P. Biatrial pacing for paroxysmal atrial fibrillation. J Am Coll Cardiol 2002;40:457–63.CrossRefPubMedGoogle Scholar
  41. 41.
    Fragakis N, Shakespeare CF, Lloyd G, et al. Reversion and maintenance of sinus rhythm in patients with permanent atrial fibrillation by internal cardioversion followed by biatrial pacing. Pacing Clin Electrophysiol 2002;25:278–86.CrossRefPubMedGoogle Scholar
  42. 42.
    Birnie D, Connors SP, Veinot JP, et al. Left atrial vein pacing: a technique of biatrial pacing for the prevention of atrial pacing. Pacing Clin Electrophysiol 2004;27:240–5.CrossRefPubMedGoogle Scholar
  43. 43.
    D’Allones GR, Pavin D, Leclerq C, et al. Long-term effects of biatrial synchronous pacing to prevent drug-refractory atrial tachycarrhythmia: a nine-year experience. J Cardiovasc Electrophysiol 2000;11:1081–91.CrossRefGoogle Scholar
  44. 44.
    Gilligan DM, Fuller IA, Clemo HF, et al. The acute effects of biatrial pacing on atrial depolarization and repolarization. Pacing Clin Electrophysiol 2000;23: 1113–20.CrossRefPubMedGoogle Scholar
  45. 45.
    Naito S, Tada H, Kaneko T, et al. Biatrial epicardial pacing prevents atrial fibrillation and confers hemodynamic benefits after coronary artery bypass surgery. Pacing Clin Electrophysiol 2005;28:S146–S149.CrossRefPubMedGoogle Scholar
  46. 46.
    Doi A, Takagi M, Toda I, et al. Acute haemodynamic benefits of biatrial atrioventricular sequential pacing: comparison with single atrial atrioventricular sequential pacing. Heart 2004;90:411–41.CrossRefPubMedGoogle Scholar
  47. 47.
    Crystal E, Connolly SJ, Sleik K, et al. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery. Circulation 2002;106:75–80.CrossRefPubMedGoogle Scholar
  48. 48.
    Debrunner M, Naegeli B, Genoni M, et al. Prevention of atrial fibrillation after cardiac valvular surgery by epicardial, biatrial synchronous pacing. Eur J Cardio-thoracic Surg 2004;25:16–20.CrossRefGoogle Scholar
  49. 49.
    Levy T, Fotopoulos G, Walker S, et al. Randomized, controlled study investigating the effect of biatrial pacing in prevention of atrial fibrillation after coronary artery bypass surgery. Circulation 2000;102:1382–7.PubMedGoogle Scholar
  50. 50.
    Greenberg MD, Katz NM, Iuliano S, et al. Atrial pacing for the prevention of atrial fibrillation after cardiovascular surgery. J Am Coll Cardiol 2000;35:1416–22.CrossRefPubMedGoogle Scholar
  51. 51.
    Gerstenfeld EP, Khoo M, Martin RC, et al. Effectiveness of bi-atrial pacing for reducing atrial fibrillation after coronary artery bypass graft surgery. J Int Card Electrophys 2001;5:275–83.CrossRefGoogle Scholar
  52. 52.
    Kurz DJ, Naegell B, Kunz M, et al. Epicardial, biatrial synchronous pacing for prevention of atrial fibrillation after cardiac surgery. Pacing Clin Electrophysiol 1999;22:721–6.CrossRefPubMedGoogle Scholar
  53. 53.
    Gerstenfeld EP, Hill MRS, French SN, et al. Evaluation of right atrial and biatrial temporary pacing for the prevention of atrial fibrillation after coronary artery bypass surgery. J Am Coll Cardiol 1999;33:1981–7.CrossRefPubMedGoogle Scholar
  54. 54.
    Wood MA, Brown-Mahoney C, Kay GN, et al. Clinical outcomes after ablation and pacing therapy for atrial fibrillation. Circulation 2000;101:1138–44.PubMedGoogle Scholar
  55. 55.
    Gillis AM, Wyse DG, Connolly SJ, et al. Atrial pacing periablation for prevention of paroxysmal atrial fibrillation. Circulation 1999;99:2553–8.PubMedGoogle Scholar
  56. 56.
    Brignole M, Gianfranchi L, Menozzi C, et al. Assessment of atrioventricular junction ablation and DDDR mode-switching pacemaker versus pharmacological treatment in patients with severely symptomatic paroxysmal atrial fibrillation. Circulation 1997;96:2617–24.PubMedGoogle Scholar
  57. 57.
    Ozcan C, Jahangir A, Friedman PA, et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N Engl J Med. 2001;344:1043–51.CrossRefPubMedGoogle Scholar
  58. 58.
    Doshi RN, Daoud EG, Fellows C, et al. Left ventricular-based cardiac stimulation post AV nodal ablation evaluation (the PAVE study). J Cardiovasc Electrophysiol 2005;16:1160–5.CrossRefPubMedGoogle Scholar
  59. 59.
    Tops LF, Schalij MJ, Holman ER, et al. Right ventricular pacing can induce ventricular dyssynchrony in patients with atrial fibrillation after atrioventricular node ablation. J Am Coll Cardiol 2006;48:1642–8.CrossRefPubMedGoogle Scholar
  60. 60.
    Gillis AM, Chung MK. Pacing the right ventricle: to pace or not to pace? Heart Rhythm 2005;2:201–6.CrossRefPubMedGoogle Scholar
  61. 61.
    Victor F, Mabo P, Mansour H, et al. A randomized comparison of permanent septal versus apical right ventricular pacing: short-term results. J Cardiovasc Electrophysiol 2006;17:238–42.CrossRefPubMedGoogle Scholar
  62. 62.
    Lieberman R, Padeletti L, Schreuder J, et al. Ventricular pacing lead location alters systemic hemodynamics and left ventricular function in patients with and without reduced ejection fraction. J Am Coll Cardiol 2006;48:1634–41.CrossRefPubMedGoogle Scholar
  63. 63.
    Gianfranchi L, Brignole M, Menozzi C, et al. Progression of permanent atrial fibrillation after atrioventricular junction ablation and dual-chamber pacemaker implantation in patients with paroxysmal atrial tachycardias. Am J Cardiol 1998;81:351–4.CrossRefPubMedGoogle Scholar
  64. 64.
    Gillis AM, Connolly SJ, Lacombe P, et al. Randomized crossover comparison of DDDR versus VDD pacing after atrioventricular junction ablation for prevention of atrial fibrillation. Circulation 2000;2102:736–41.Google Scholar
  65. 65.
    McComb JM, Gribbin GM. Chronic atrial fibrillation in patients with paroxysmal atrial fibrillation, atrioventricular node ablation and pacemakers. Europace 1999;1:30–34.CrossRefPubMedGoogle Scholar
  66. 66.
    Willems R, Wyse DG, Gillis AM. Atrial Pacing Periablation for Paroxysmal Atrial Fibrillation (PA3) Study Investigators. Total atrioventricular nodal ablation increases atrial fibrillation burden in patients with paroxysmal atrial fibrillation despite continuation of antiarrhythmic drug therapy. J Cardiovasc Electrophysiol. 2003;14:1296–301.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • Michael A. Platonov
    • 1
  • Anne M. Van Hare
    • 2
  1. 1.Cardiac SciencesUniversity of CalgaryCalgaryCanada
  2. 2.Department of Cardiac SciencesHealth Sciences CentreCalgaryCanada

Personalised recommendations